SCHEMBL575461

SCHEMBL575461

CCCCOP(C)(=O)OCCCC

nearest known ligand 0.67

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.67
LPAR3 Q9UBY5 5/20 0.50
LPAR1 Q92633 3/20 0.50
LPAR2 Q9HBW0 3/20 0.50
TSHR P16473 1/20 0.50
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14354700 0.93 CYP3A4 (0.58) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL13450135 0.93 LPAR3 (0.61) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL13634495 0.93 LPAR3 (0.61) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL777294 0.92 LPAR3 (0.60) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL28660473 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2
SCHEMBL6237188 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2
SCHEMBL387266 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2
SCHEMBL11123884 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2
SCHEMBL6625594 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2
SCHEMBL27711778 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119475702-A Parameter optimization design method for heteropolar rotor DC hybrid magnetic bearing 淮阴工学院 2025-02-18 CN claimed
EP-3780845-B1 METHOD AND DEVICE FOR DETERMINING TRANSMISSION TIME IN WIRELESS COMMUNICATION SYSTEM SAMSUNG ELECTRONICS CO LTD (KR) 2024-06-26 EP claimed
CN-118136801-A Lithium-containing phosphate positive electrode material, and preparation method and application thereof 曲靖市德方纳米科技有限公司 2024-06-04 CN claimed
CN-115724734-A Method for separating and extracting lactic acid, lactic acid product and preparation method thereof, and preparation method of calcium lactate particles 上海凯赛生物技术股份有限公司 2023-03-03 CN claimed
US-20220331267-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF DEMYELINATING DISORDERS RUSH UNIVERSITY MEDICAL CENTER (US) 2022-10-20 US claimed
US-9938451-B2 Enhanced electrolytic degradation of controlled electrolytic material BAKER HUGHES, A GE COMPANY, LLC (US) 2018-04-10 US claimed
US-20160009986-A1 ENHANCED ELECTROLYTIC DEGRADATION OF CONTROLLED ELECTROLYTIC MATERIAL BAKER HUGHES INCORPORATED (US) 2016-01-14 US claimed
WO-2013070419-A1 ENHANCED ELECTROLYTIC DEGRADATION OF CONTROLLED ELECTROLYTIC MATERIAL BAKER HUGHES INCORPORATED (US) 2013-05-16 WO claimed
US-20130112429-A1 ENHANCED ELECTROLYTIC DEGRADATION OF CONTROLLED ELECTROLYTIC MATERIAL BAKER HUGHES INCORPORATED (US) 2013-05-09 US claimed
US-20110021803-A1 PURIFICATION AND PREPARATION OF PHOSPHORUS-CONTAINING COMPOUNDS SIGMA-ALDRICH CO. NEWCO INC. 2011-01-27 US claimed
EP-2265621-A2 PURIFICATION AND PREPARATION OF PHOSPHORUS-CONTAINING COMPOUNDS Sigma-Aldrich Co. (US) 2010-12-29 EP claimed
WO-2009117583-A2 PURIFICATION AND PREPARATION OF PHOSPHORUS-CONTAINING COMPOUNDS SIGMA-ALDRICH, CO (US) 2009-09-24 WO claimed
US-7291478-B1 Rapid screening and analysis of present and potential nerve agents and their degradation products THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2007-11-06 US claimed
US-6096447-A NONAQUEOUS ELECTROCHEMICAL CELL CAPABLE OF DELIVERING HIGH CURRENT PULSES, RAPIDLY RECOVERING ITS OPEN CIRCUIT VOLTAGE AND HAVING HIGH CURRENT CAPACITY WILSON GREATBATCH LTD. (US) 2000-08-01 US claimed
EP-1005098-A2 Alkali metal electrochemical cell having an improved cathode activated with a nonaqueous electrolyte having a passivation inhibitor additive WILSON GREATBATCH LTD. (US) 2000-05-31 EP claimed
EP-0917224-A1 Phosphonate additives for non-aqueous electrolyte in alkali metal electrochemical cells WILSON GREATBATCH LTD. (US) 1999-05-19 EP claimed
CN-120505386-B Method for modifying protein in open environment and protein modifier PEKING UNIVERSITY SCHOOL OF STOMATOLOGY (CN) 2026-05-26 CN disclosed
US-12606656-B2 Telechelic polymers based on ethylene and 1,3 diene COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2026-04-21 US disclosed
US-4075139-A PROCESS OF MAKING A CURED RESOLE FOAM AND PRODUCT PRODUCED THEREFROM THE UPJOHN COMPANY (US) 1978-02-21 US disclosed
US-3979458-A Production of unsaturated carbocyclic ketones SYNTEX CORPORATION (PM) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220331267-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF DEMYELINATING DISORDERS PPARA, PPARG, PPARD CYP3A4 2761/4885LPAR3 706/4885LPAR1 552/4885
US-12606656-B2 Telechelic polymers based on ethylene and 1,3 diene TCP1, EEF1D, ECH1 CYP3A4 3672/4885LPAR3 3289/4885LPAR1 2981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.